Prostate Cancer Risk Groups

Prostate Cancer Risk Group is the most common way that doctors determine the aggressiveness of a particular cancer. Each risk group indicates how quickly the prostate cancer will grow and how likely it is to spread outside of the prostate. Recommendations regarding which forms or combination of forms of treatment are highly influenced by the particular risk category of a patient.

 

What Three Things Determine Your Risk Group?

Your Prostate Specific Antigen or PSA

PSA results are derived from a recent blood test. PSA is produced in the blood by prostate cells, but production is accelerated when cells become cancerous. As the blood test is simple to administer, it is usually the first sign of prostate cancer. To discover out what levels are normal, learn more about PSA.

Your Prostate Cancer Stage

Stage is determined by analysis of one or multiple tests. The stage of your cancer describes the progression within and beyond your prostate. Early prostate cancer is usually localized or confined to the prostate. As the cancer grows, the cancer may begin penetrate the prostate capsule, invading local organs then to distant parts of the body.

Your Gleason Score

Gleason score is determined by taking multiple samples during a biopsy of the prostate. The usual number of biopsy specimens obtained is around 10 to 12. Analysis of these samples by a pathologist using a grading system called the Gleason system determines the Gleason score, which in turn helps determine your risk group. The higher your Gleason score, the higher your risk group.

Is Your Prostate Cancer Risk Group: Low, Intermediate or High?

Select your risk group to see which treatments are most successful for your risk group.

Low Risk

PSA less than 10
and
Gleason Score less than 7
and
Clinical Stage is T1c to T2a

Intermediate Risk

PSA greater than 10 less than 20
or
Gleason Score is 7
or
Clinical Stage is T2b

High Risk

PSA greater than 20
or
Gleason Score is 8 to 10
or
Clinical Stage is T2c to T3c

Prostate Cancer Free

Thirty Six Prostate Cancer Experts have analyzed the treatment outcomes of over 100,000 patients across the globe, following these patients for up to 15 years. The success of a treatment is determined by monitoring PSA for years after treatment. This data is presented to you, so you can see which treatments leave patients prostate cancer free. Watch this video to learn more.

  UNDERSTAND PROSTATE CANCER.

What is Prostate Cancer?

Do you have questions about Prostate Cancer? Do you know the Symptoms? The Causes? Has someone you know expressed concern that they might have Prostate Cancer?

Diagnosed with Prostate Cancer?

Recently diagnosed patients and families should do all they can to learn about the tests and treatment options in the fight against prostate cancer.

Treating Prostate Cancer.

Most patients have options when it comes to the treatment of prostate cancer. Learn about your prostate cancer treatment options.

Explore Common Prostate Cancer Terms

To Learn More, Click on Any of the Terms Below

Help other men make better treatment decisions.

A $25 donation today helps us continue the groundbreaking working of the Prostate Cancer Treatment Study Group.